- Home
- FOSL vs OKYO Comparison
FOSL vs OKYO Comparison
Compare FOSL & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOSL
- OKYO
- Stock Information
- Founded
- FOSL 1984
- OKYO 2007
- Country
- FOSL United States
- OKYO United Kingdom
- Employees
- FOSL N/A
- OKYO N/A
- Industry
- FOSL Consumer Specialties
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FOSL Consumer Discretionary
- OKYO Health Care
- Exchange
- FOSL Nasdaq
- OKYO Nasdaq
- Market Cap
- FOSL 100.0M
- OKYO 95.3M
- IPO Year
- FOSL 1993
- OKYO 2022
- Fundamental
- Price
- FOSL $3.10
- OKYO $2.65
- Analyst Decision
- FOSL Strong Buy
- OKYO Strong Buy
- Analyst Count
- FOSL 1
- OKYO 1
- Target Price
- FOSL $5.00
- OKYO $7.00
- AVG Volume (30 Days)
- FOSL 772.3K
- OKYO 169.5K
- Earning Date
- FOSL 08-13-2025
- OKYO 07-18-2025
- Dividend Yield
- FOSL N/A
- OKYO N/A
- EPS Growth
- FOSL N/A
- OKYO N/A
- EPS
- FOSL N/A
- OKYO N/A
- Revenue
- FOSL $1,083,797,000.00
- OKYO N/A
- Revenue This Year
- FOSL N/A
- OKYO N/A
- Revenue Next Year
- FOSL N/A
- OKYO N/A
- P/E Ratio
- FOSL N/A
- OKYO N/A
- Revenue Growth
- FOSL N/A
- OKYO N/A
- 52 Week Low
- FOSL $0.86
- OKYO $0.85
- 52 Week High
- FOSL $3.22
- OKYO $3.35
- Technical
- Relative Strength Index (RSI)
- FOSL 86.95
- OKYO 44.50
- Support Level
- FOSL $1.63
- OKYO $2.58
- Resistance Level
- FOSL $1.68
- OKYO $3.35
- Average True Range (ATR)
- FOSL 0.19
- OKYO 0.27
- MACD
- FOSL 0.11
- OKYO -0.06
- Stochastic Oscillator
- FOSL 92.86
- OKYO 21.37
About FOSL Fossil Group Inc.
Fossil Group Inc is a design, innovation and distribution company in consumer fashion accessories. The products include traditional watches, smartwatches, jewelry, handbags, small leather goods, belts and sunglasses. The reportable segments are comprised of 1) Americas segment includes sales in Canada, Latin America and the United States. 2) Europe segment includes sales in European countries, the Middle East and Africa. 3) Asia segment includes sales in Australia, China, India, Indonesia, Japan, Malaysia, New Zealand, Singapore, South Korea and Thailand. Each reportable operating segment includes sales to wholesale and distributor customers, and sales through Company-owned retail stores and e-commerce activities based on the location of the selling entity.
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.